HDFC Pharma and Healthcare Fund vs UTI Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
UTI Healthcare Fund - Regular Plan - Growth Option
Chart Comparison
Overview
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Fund | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹1936 Cr | ₹1146 Cr |
Min Investment | ₹100 | ₹5000 |
Min SIP Invesment | ₹100 | ₹500 |
Min Addl Investment | ₹100 | ₹1000 |
Launch Date | 04 Oct 2023 | 30 Jul 2005 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare Index | BSE Healthcare |
Turn Over | % | 28% |
Expense Ratio | 2.14 | 2.22 |
Manager | Dhruv Muchhal | Kamal Gada |
ISIN Code | INF179KC1HL7 | INF789F01695 |
Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | UTI Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Month | -1.01% | 0.5% |
6 Month | 14.56% | 14.82% |
1 Year | 13.13% | 8.33% |
3 Year | - | 26.06% |
5 Year | - | 18.68% |
SIP Return Analysis
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
6 Month | 6.63% | 7.35% |
1 Year | 15.08% | 12.76% |
3 Year | - | 27.19% |
5 Year | - | 20.91% |
Rolling Lumpsum Returns
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
1 Year | 29.56% | 12.22% |
3 Year | - | 16.31% |
5 Year | - | 14.54% |
Risk Management
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Standard Deviation | - | 15.43% |
Sharp | - | 1.18% |
Beta | - | 0.96% |
Alpha | - | 1.23% |
Fund Managers
Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Name | Dhruv Muchhal | Kamal Gada |
Total AUM | ₹520687 Cr | ₹870 Cr |
Funds Managed | 40 | 1 |
HDFC Pharma and Healthcare Fund - Regular (G) | UTI Healthcare Fund - Regular Plan - Growth Option |
Market Cap
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 8.44 | 5.33 |
Mid Cap | 24.57 | 31.48 |
Small Cap | 37.01 | 40.07 |
Large Cap | 29.99 | 23.12 |
Sector Allocation
Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
UTI Healthcare Fund - Regular Plan - Growth Option |
---|---|---|
Others | 1.8 | 2.34 |
Basic Materials | 2.27 | 1.03 |
Healthcare | 95.93 | 96.62 |
Top Comparisons
HDFC Multi-Asset Active FOF - Growth
3Y Returns15.65%
HSBC Aggressive Hybrid Active FOF - Growth
3Y Returns14.68%
Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth
3Y Returns12.6%
UTI Aggressive Hybrid Fund- Regular Plan - Growth
3Y Returns16.23%
Mahindra Manulife ELSS Tax Saver Fund- Regular Plan - Growth
3Y Returns14.35%
BARODA BNP PARIBAS ELSS TAX SAVER FUND GROWTH- REGULAR GROWTH
3Y Returns17.95%
DSP Arbitrage Fund - Regular - Growth
3Y Returns6.89%
Axis Arbitrage Fund - Regular Plan - Growth
3Y Returns6.84%